ArticleBMC microbiology2025
Optimization of fermentation conditions and extracellular metabolic profiling of Streptomyces rochei strain W71.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to determine the optimal fermentation conditions and to characterize extracellular differential metabolites of Streptomyces rochei strain W71. The inhibition rate of its fermentation supernatant against Phytophthora nicotianae was used as the evaluation index to assess anti-oomycete activity.
methodsThe fermentation conditions of strain W71 were optimized through single-factor experiments combined with response surface methodology (RSM: Plackett–Burman design, steepest ascent, and Box–Behnken design). Untargeted liquid chromatography–mass spectrometry (LC–MS) metabolomic analysis was then performed to identify extracellular metabolites and elucidate the key metabolic pathways involved.
resultsThe optimal fermentation conditions for strain W71 were as follows: maltose: 20.0 g/L, yeast extract powder: 2.5 g/L, NaCl: 1.0 g/L, working volume: 100 mL/250 mL, inoculum size: 5.55%, agitation speed: 200 rpm, initial pH: 8.66, temperature: 29.8 ℃, and fermentation time: 8 days. Under these conditions, the inhibition rate of the fermentation broth reached 92.90%, representing a 6.78-fold increase compared with the pre-optimization level. LC–MS metabolomic analysis identified 1,771 differential metabolites in extracellular extracts after optimization, of which 1,479 were upregulated and 292 were downregulated. The major metabolite classes included organic halogen compounds, organic acids and derivatives, and aromatic metabolites. KEGG enrichment analysis revealed 20 significantly altered pathways, among which ABC transporters, amino acid biosynthesis, and the pentose phosphate pathway were identified as key metabolic routes.
conclusionOptimization of fermentation conditions for strain W71 significantly enhanced the antifungal activity of its fermentation broth against P. nicotianae and altered extracellular metabolic pathways, leading to substantial regulation of extracellular metabolite profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.